Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds
Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds: a Multicenter Randomized Controlled Trial
Assistance Publique - Hôpitaux de Paris
98 participants
Oct 4, 2023
INTERVENTIONAL
Conditions
Summary
Refer to "Detailed description".
Eligibility
Inclusion Criteria4
- Patient >18 years of age with a smelly wound (discomfort > 4/10 expressed by the patient);
- Predictive wound healing >14 days (clinical judgement);
- Patient benefiting from a social security scheme (AME excluded)
- Patient, and curator if applicable, informed and having signed the consent form for participation in the study
Exclusion Criteria8
- Patient already receiving a secondary charcoal or cinnamon dressing
- Patient with pressure ulcer stage 1 or 2
- Patient treated by metronidazole or antimicrobial for < 3 days;
- Patient who cannot communicate his feelings;
- Anosmic patient;
- Patient with cinnamon allergy;
- Persons deprived of their liberty or under guardianship;
- Inability to submit to the medical follow-up of the trial for geographical, social, psychological or cognitive reasons.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Use of CINESTEAM® as a non-occlusive secondary dressing CE marked medical device class I, secondary, absorbent, non-adhesive and composed of: * Anti-odor upper part, adsorbent containing cinnamon powder. * Weakly absorbent lower part intended to absorb excess exudates.
Use of a secondary non-occlusive activated charcoal dressing (brand of your choice)
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05685628